Antiproliferative Activity and Induction of Apoptosis in PC-3 Cells by the Chalcone Cardamonin from Campomanesia adamantium (Myrtaceae) in a Bioactivity-Guided Study

Molecules

Volumn 19, Issue 2, 2014, Pages 1843-1855

  Pascoal, Aislan Cristina Rheder Fagundes ^a   Ehrenfried, Carlos Augusto ^b   Lopez, Begoña Gimenez Cassina ^a   De Araujo, Thiago Matos ^a   Pascoal, Vinicius D'ávila Bitencourt ^c   Gilioli, Rovilson ^a   Anheê, Gabriel Forato ^a   Ruiz, Ana Lúcia Tasca Goes ^d   De Carvalho, João Ernesto ^d   Stefanello, Mariaélida Alves ^b   Salvador, Marcos José ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^d Division of Pharmacology and Toxicology   (Brazil)

Author keywords

Campomanesia adamantium; Myrtaceae; chalcone; cardamonin; apoptosis; cancer

Indexed keywords

CARDAMONIN; CHALCONE; CHALCONE DERIVATIVE; PLANT EXTRACT;

APOPTOSIS; ARTICLE; BRAZIL; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; HUMAN; MALE; MYRTACEAE; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

APOPTOSIS; BRAZIL; CELL LINE, TUMOR; CELL PROLIFERATION; CHALCONE; CHALCONES; HUMANS; MALE; MYRTACEAE; PLANT EXTRACTS; PROSTATIC NEOPLASMS;

EID: 84894640317     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19021843     Document Type: Article

References (29)

1. Brandão, H.N.; David, J.P.; Couto, R.D.; Nascimento, J.A.P.; David, J.M. Química e Farmacologia de Quimioterápicos Antineoplásicos Derivados de Plantas. Quim. Nova 2010, 33, 1359-1369.
2. Newman, D.J.; Cragg, G.M.; Snader, K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 2003, 66, 1022-1037.
3. Newman, D.J.; Cragg, G.M.; Snader, K.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012, 75, 311-335.
4. Stefanello, M.E.A.; Pascoal, A.C.R.F.; Salvador, M.J. Essential oils from neo-tropical myrtaceae: Chemical diversity and biological properties. Chem. Biodivers. 2011, 8, 73-94.
5. Lorenzi, H. árvores Brasileiras: Manual de Identificaç ão e Cultivo de Plantas Arböreas Nativas do Brasil, 1st ed.; Editora Plantarum: Nova Odessa, Brazil, 2002; p. 352.
6. Pavan, F.R.; Leite, C.Q.F.; Coelho, R.G.; Coutinho, I.D.; Honda, N.K.; Cardoso, C.A.L.; Vilegas, W.; Leite, S.R.A.; Sato, D.N. Evaluation of anti-mycobacterium tuberculosis activity of Campomanesia adamantium (Myrtaceae). Quim. Nova 2009, 32, 1222-1226.
7. Coutinho, I.D.; Coelho, R.G.; Kataoka, V.M.F.; Honda, N.K.; Silva, J.R.M.; Vilegas, W.; Cardoso, C.A.L. Determination of phenolic compounds and evaluation of antioxidant capacity of Campomanesia adamantium leaves. Ecletíca Quím. 2008, 33, 53-60.
8. Pascoal, A.C.R.F.; Erenfried, C.A.; Eberlin, M.N.; Stefanello, M.E.A.; Salvador, M.J. Free radical scavenging activity, determination of phenolic compounds and HPLC-DAD/ESI-MS profile of Campomanesia adamantium leaves. Nat. Prod. Commun. 2011, 6, 969-972.
9. Ferreira, L.C.; Grabe-Guimarães, A.; de Paula, C.A.; Michel, M.C.P.; Guimarães, R.G.; Rezende, S.A.; de Souza-Filho, J.D.; Guimarães, D.A.S. Anti-inflammatory and antinociceptive activities of Campomanesia adamantium. J. Ethnopharmacol. 2013, 145, 100-108.
10. Zi, X.; Simoneau, A.R.; Flavokawain, A. A novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Cancer Res. 2005, 65, 3479-3486.
11. Solomon, V.R.; Lee, H. Anti-breast cancer activity of heteroaryl chalcone derivatives. Biomed. Pharmacother. 2012, 66, 213-220.
12. Itokawa, H.; Morita, M.; Mihashi, S. Phenolic compounds from the rhizomes of Alpinia speciosa. Phytochemistry 1981, 20, 2503-2506.
13. Kamal, A.; Mallareddy, A.; Suresh, P.; Shaik, T.B.; Lakshma-Nayak, V.; Kishor, C.; Shetti, R.V.; Sankara-Rao, N.; Tamboli, J.R.; Ramakrishna, S.; et al. Synthesis of chalcone-amidobenzothiazole conjugates as antimitotic and apoptotic inducing agents. Bioorg. Med. Chem. 2012, 20, 3480-3492.
14. Baldwin, A.S. Series introduction: The transcription factor of NFk-B and humam disease. J. Clin. Invest. 2001, 107, 3-6.
15. Karin, M.; Cao, Y.; Greten, F.R.; Li, Z.W. NFk-B in cancer: From innocent bystander to major culprit. Nat. Rev. Cancer 2002, 2, 301-310.
16. Luo, J.L.; Maeda, S.; Hsu, L.C.; Yagita, H.; Karin, M. Inhibition of NFk-B in cancer cells converts inflammation-induced tumor growth mediated by TNFa to TRAIL-mediated tumor regression. Cancer Cell. 2004, 6, 297-305.
17. Sladkova, L.V.; Moskaleva, E.V.; Posypanova, G.A. Apoptosis of cells of different lines and the characteristics of internucleosomal DNA fragmentation in cells: connection with the cell cycle. Tsitologiia 2000, 42, 309-313.
18. Rahman, M.A. Chalcone: A valuable insight into the recent advances and potential pharmacological activities. Chem. Sci. J. 2011, 29, 1-16.
19. Syam, S.; Abdelwahab, S.I.; Al-Mamary, M.A.; Mohan, S. Synthesis of chalcones with anticancer activities. Molecules 2012, 17, 6179-6195.
20. Szliszka, E.; Czuba, Z.P.; Mazur, B.; Paradysz, A.; Krol, W. Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells. Molecules 2010, 15, 5336-5353.
21. Simirgiotis, M.J.; Adachi, S.; To, S.; Yanga, H.; Reynertson, K.A.; Basile, M.; Gil, J.R.R.; Weinsteinb, I.B.; Kennellya, E.J. Cytotoxic chalcones and antioxidants from the fruits of Syzygium samarangense (Wax Jambu). Food Chem. 2008, 107, 813-819.
22. Park, S.; Gwak, J.; Han, S.J.; Oh, S. Cardamonin suppresses the proliferation of colon cancer cells by promoting β-catenin degradation. Biolog. Pharm. Bull. 2013, 36, 1040-1044.
23. Qin, Y.; Sun, C.Y.; Lu, F.R.; Shu, X.R.; Yang, D.; Chen, L.; She, X.M.; Gregg, N.M.; Guo, T.; Hu, Y. Cardamonin exerts potent activity against multiple myeloma through blockade of NF-κB pathway in vitro. Leuk. Res. 2012, 36, 514-520.
24. Teodori, E.; Dei, S.; Scapecchi, S.; Gualtieri, F. The medicinal chemistry of Multidrug Resistence Reversing Drugs (MRD). Farmaco 2002, 57, 385-414.
25. Baguley, B.C. Multiple drug resistence mechanisms in cancer. Mol. Biotechnol. 2010, 46, 308-316.
26. Kale, A.; Gawande, S.; Kotwal, S. Cancer phytotherapeutics: Role for flavonoids at the cellular level. Phytother. Res. 2008, 22, 567-577.
27. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; Mcmahon, J.; Vistica, D.; Warren, J.T.; Bokesch, H.; Kenney, S.; Boyd, M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Nat. Cancer Instit. 1990, 82, 1107-1118.
28. Shoemaker, R.H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer 2006, 6, 813-823.
29. Nicoletti-Carvalho, J.E., Nogueira, T.C.A.; Gorjão, R.; Bromati, C.R.; Yamanaka, T.S.; Boschero, A.C.; Velloso, L.A.; Curi, R.; Anhê, G.F.; Bordin, S. UPR-mediated TRIB3 expression correlates with reduced AKT phosphorylation and inability of interleukin 6 to overcome palmitate-induced apoptosis in RINm5F cells. J. Endocrinol. 2010, 206, 183-193.